368 results on '"Tourbah, Ayman"'
Search Results
2. Cohortes digitales, mythe ou réalité ? Analyse descriptive des utilisateurs français de MSCopilot®
3. MSCopilot: New smartphone-based digital biomarkers correlate with Expanded Disability Status Scale scores in people with Multiple Sclerosis
4. Aquaporin 4 distribution in the brain and its relevance for the radiological appearance of neuromyelitis optica spectrum disease
5. Reasons for switching to fingolimod in patients relapsing-remitting multiple sclerosis in France: the ESGILE study
6. Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients
7. Expert opinion: Criteria for second-line treatment failure in patients with multiple sclerosis
8. Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial
9. Anxiety and depression in patients with multiple sclerosis: The mediating effects of perceived social support
10. Cognition and quality of life in clinically isolated syndrome patients starting a disease modifying therapy in the QUALICIS study may not predict treatment response at one year
11. Targeting demyelination and virtual hypoxia with high-dose biotin as a treatment for progressive multiple sclerosis
12. Efficacy and safety profile of memantine in patients with cognitive impairment in multiple sclerosis: A randomized, placebo-controlled study
13. Comparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosis
14. High doses of biotin in chronic progressive multiple sclerosis: A pilot study
15. Long-Term Effectiveness, Safety and Tolerability of Fingolimod in Patients with Multiple Sclerosis in Real-World Treatment Settings in France: The VIRGILE Study
16. Clinical and MRI characterization of MS patients with a pure and severe cognitive onset
17. Normalisation of brain spectroscopy findings in Niemann–Pick disease type C patients treated with miglustat
18. Criteria improving multiple sclerosis diagnosis at the first MRI
19. Prospective Characterization of Brain T2 Lesions Suggestive of Demyelination in Asymptomatic Patients diagnosed as Radiologically Isolated Syndrome (P14-4.011)
20. The neuronal component of gray matter damage in multiple sclerosis: A [11C]flumazenil positron emission tomography study
21. 24 month-treatment with miglustat of three patients with Niemann-Pick disease type C: Follow up using brain spectroscopy
22. Serum Neurofilament Levels and PML Risk in Patients With Multiple Sclerosis Treated With Natalizumab
23. Cancer and multiple sclerosis in the era of disease-modifying treatments
24. Utilisation du natalizumab dans la sclérose en plaques : la deuxième révolution thérapeutique
25. Brain Networks Disconnection in Early Multiple Sclerosis Cognitive Deficits: An Anatomofunctional Study
26. Switching From Natalizumab to Fingolimod in Multiple Sclerosis: A French Prospective Study
27. Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosis
28. Social cognition and executive functioning in multiple sclerosis: A cluster‐analytic approach
29. Aquaporin 4 distribution in the brain and its relevance for the radiological appearance of neuromyelitis optica spectrum disease
30. Serum Neurofilament Levels and PML Risk in Patients With Multiple Sclerosis Treated With Natalizumab
31. Optical Coherence Tomography in Neuro-Ophthalmology
32. Interferons in multiple sclerosis: Ten years' experience
33. Phénotypes et degré d’incapacité lié à la sclérose en plaques : facteurs d’influence des paramètres fonctionnels en vie réelle – analyse de la base MSCopilot®
34. Relation entre mémoire épisodique verbale et compétences en cognition sociale dans la sclérose en plaques
35. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
36. Outcomes of coronavirus disease 2019 in patients with neuromyelitis optica and associated disorders
37. Association Between Clinical Conversion to Multiple Sclerosis in Radiologically Isolated Syndrome and Magnetic Resonance Imaging, Cerebrospinal Fluid, and Visual Evoked Potential: Follow-up of 70 Patients
38. Social cognition and executive functioning in multiple sclerosis: A cluster‐analytic approach.
39. MSJ849511_supplemental_figure – Supplemental material for Frequency and characteristics of short versus longitudinally extensive myelitis in adults with MOG antibodies: A retrospective multicentric study
40. Another Mutation in Cysteine 131 in Protein Kinase Cγ as a Cause of Spinocerebellar Ataxia Type 14
41. Outcomes of coronavirus disease 2019 in patients with neuromyelitis optica and associated disorders.
42. Sarcoid related optochiasmatic arachnoiditis: favourable outcome confirmed with MRI
43. Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults
44. Frequency and characteristics of short versus longitudinally extensive myelitis in adults with MOG antibodies: A retrospective multicentric study
45. Clinical Evaluation of a Software Medical Device for the Self-Assessment of Patients Living with Multiple Sclerosis: Results of the MSCopilot Study (P3.2-012)
46. Effect of MD1003 (high dose Pharmaceutical grade Biotin) in the Treatment of Progressive MS: Earlier Treatment Results in Lower Disability Over 48 Months (P3.2-063)
47. Effect of MD1003 (high dose Pharmaceutical grade Biotin) in the Treatment of Progressive MS: Long-term Safety Data at 48 Months of Follow-up (P3.2-043)
48. Biotin in Progressive Multipe Sclerosis in real-life (P3.2-083)
49. Évaluation clinique d’une application smartphone pour l’auto-évaluation des patients atteints de sclérose en plaques (SEP) : résultats de l’étude multicentrique MSCopilot
50. Satisfaction des patients atteints de sclérose en plaques rémittente-récurrente (SEP-RR) en France vis-à-vis du traitement par le fingolimod prescrit après un échec d’une thérapeutique de première ligne (Étude ESGILE)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.